Clinical Trial Update: Efficacy Study in Removing Excess Iron From the Heart [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports completion of an efficacy study evaluating removal of excess iron from the heart in patients with thalassemia major and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemosiderosis
• Thalassemia Major

Snippet

Sponsor: ApoPharma | Conditions: Thalassemia Major, Hemosiderosis | Phase 4 | Status: COMPLETED